Joe Putnam
Faculty Member
Last active: 3/27/2014

  1. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R (2004) Int J Radiat Oncol Biol Phys 60(5): 1484-93
    › Primary publication · 15590179 (PubMed)
  2. Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J, Fossella FV, Allen P, Komaki R (2004) Int J Radiat Oncol Biol Phys 58(1): 204-12
    › Primary publication · 14697440 (PubMed)
  3. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA (2004) Am J Gastroenterol 99(7): 1258-66
    › Primary publication · 15233663 (PubMed)
  4. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA (2004) Cancer 101(8): 1776-85
    › Primary publication · 15386332 (PubMed)
  5. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J (2003) Ann Thorac Surg 76(4): 1001-7; discussion 1007-8
    › Primary publication · 14529975 (PubMed)
  6. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CP (2003) Urol Oncol 21(5): 327-33
    › Primary publication · 14670538 (PubMed)
  7. Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. Sabloff B, Munden RF, Melhem AI, El-Naggar AK, Putnam JB (2003) AJR Am J Roentgenol 180(4): 972
    › Primary publication · 12646438 (PubMed)
  8. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J, Fossella F, Allen P, Cox JD, Komaki R (2003) Int J Radiat Oncol Biol Phys 56(3): 616-25
    › Primary publication · 12788166 (PubMed)
  9. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R (2003) Int J Radiat Oncol Biol Phys 57(5): 1317-22
    › Primary publication · 14630268 (PubMed)
  10. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA (2003) Int J Radiat Oncol Biol Phys 57(1): 120-7
    › Primary publication · 12909224 (PubMed)